

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.96553174 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.89565549 |
| 3 | vocalization behavior (GO:0071625) | 4.43493344 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.40488229 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34532575 |
| 6 | protein localization to synapse (GO:0035418) | 4.28139102 |
| 7 | regulation of cell communication by electrical coupling (GO:0010649) | 4.26908783 |
| 8 | glutamate secretion (GO:0014047) | 4.24670315 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.22032807 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16898234 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.10344129 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.02294745 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.01121101 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.00638539 |
| 15 | proline transport (GO:0015824) | 3.96503068 |
| 16 | locomotory exploration behavior (GO:0035641) | 3.94837117 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 3.92317394 |
| 18 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.90123593 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.84531880 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83364569 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.78863672 |
| 22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.77734276 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.75187712 |
| 24 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.74785225 |
| 25 | presynaptic membrane assembly (GO:0097105) | 3.73929460 |
| 26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.72961059 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.72300929 |
| 28 | auditory behavior (GO:0031223) | 3.67464311 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 3.65990990 |
| 30 | cell communication involved in cardiac conduction (GO:0086065) | 3.65759775 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.61626873 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 3.59974713 |
| 33 | positive regulation of action potential (GO:0045760) | 3.59944266 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 3.55076210 |
| 35 | exploration behavior (GO:0035640) | 3.50250811 |
| 36 | membrane assembly (GO:0071709) | 3.46106904 |
| 37 | innervation (GO:0060384) | 3.46098801 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.42043198 |
| 39 | long-term synaptic potentiation (GO:0060291) | 3.40459362 |
| 40 | response to histamine (GO:0034776) | 3.40058586 |
| 41 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.35935352 |
| 42 | presynaptic membrane organization (GO:0097090) | 3.35074806 |
| 43 | regulation of membrane repolarization (GO:0060306) | 3.34400526 |
| 44 | neuron recognition (GO:0008038) | 3.33863289 |
| 45 | neurotransmitter secretion (GO:0007269) | 3.33321062 |
| 46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.32922729 |
| 47 | cardiac myofibril assembly (GO:0055003) | 3.32464860 |
| 48 | regulation of actin filament-based movement (GO:1903115) | 3.31529683 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31068031 |
| 50 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.27119073 |
| 51 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.25079707 |
| 52 | layer formation in cerebral cortex (GO:0021819) | 3.23938021 |
| 53 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.22336448 |
| 54 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.22224087 |
| 55 | membrane hyperpolarization (GO:0060081) | 3.20426462 |
| 56 | regulation of dendritic spine development (GO:0060998) | 3.18067210 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.17597383 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17102337 |
| 59 | startle response (GO:0001964) | 3.16662834 |
| 60 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.15771354 |
| 61 | regulation of postsynaptic membrane potential (GO:0060078) | 3.15133087 |
| 62 | neuronal action potential propagation (GO:0019227) | 3.14419335 |
| 63 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.14137454 |
| 64 | cardiac muscle contraction (GO:0060048) | 3.13161399 |
| 65 | regulation of sarcomere organization (GO:0060297) | 3.12416857 |
| 66 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.12400122 |
| 67 | axonal fasciculation (GO:0007413) | 3.12025601 |
| 68 | alanine transport (GO:0032328) | 3.10250229 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.09971849 |
| 70 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08817396 |
| 71 | long-term memory (GO:0007616) | 3.08221800 |
| 72 | neuronal action potential (GO:0019228) | 3.07466193 |
| 73 | response to gravity (GO:0009629) | 3.06942636 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06936504 |
| 75 | C4-dicarboxylate transport (GO:0015740) | 3.04863179 |
| 76 | regulation of synapse structural plasticity (GO:0051823) | 3.02954598 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 3.02582228 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.00516089 |
| 79 | activation of protein kinase A activity (GO:0034199) | 2.99860656 |
| 80 | cellular response to epinephrine stimulus (GO:0071872) | 2.99255039 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.98458095 |
| 82 | negative regulation of dendrite development (GO:2000171) | 2.96887875 |
| 83 | regulation of relaxation of muscle (GO:1901077) | 2.95729391 |
| 84 | long term synaptic depression (GO:0060292) | 2.93936488 |
| 85 | cell communication by electrical coupling (GO:0010644) | 2.93911330 |
| 86 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91526575 |
| 87 | sodium ion export (GO:0071436) | 2.91232009 |
| 88 | behavioral fear response (GO:0001662) | 2.90649188 |
| 89 | behavioral defense response (GO:0002209) | 2.90649188 |
| 90 | regulation of synapse assembly (GO:0051963) | 2.89712040 |
| 91 | postsynaptic membrane organization (GO:0001941) | 2.88944090 |
| 92 | mechanosensory behavior (GO:0007638) | 2.87752590 |
| 93 | detection of calcium ion (GO:0005513) | 2.87199951 |
| 94 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.86872819 |
| 95 | regulation of synapse maturation (GO:0090128) | 2.86415421 |
| 96 | response to auditory stimulus (GO:0010996) | 2.86110678 |
| 97 | positive regulation of membrane potential (GO:0045838) | 2.85812542 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 2.85753269 |
| 99 | regulation of action potential (GO:0098900) | 2.85753208 |
| 100 | neurotransmitter transport (GO:0006836) | 2.84891679 |
| 101 | myofibril assembly (GO:0030239) | 2.84162626 |
| 102 | dendritic spine morphogenesis (GO:0060997) | 2.83957474 |
| 103 | central nervous system neuron axonogenesis (GO:0021955) | 2.83662139 |
| 104 | regulation of neurotransmitter secretion (GO:0046928) | 2.82039437 |
| 105 | synapse assembly (GO:0007416) | 2.81562394 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.80841881 |
| 107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.79713958 |
| 108 | gamma-aminobutyric acid transport (GO:0015812) | 2.79652882 |
| 109 | transmission of nerve impulse (GO:0019226) | 2.79479584 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 2.79372238 |
| 111 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.79230928 |
| 112 | response to epinephrine (GO:0071871) | 2.77437979 |
| 113 | membrane depolarization (GO:0051899) | 2.77403966 |
| 114 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.76725968 |
| 115 | muscle cell cellular homeostasis (GO:0046716) | 2.76274409 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74865765 |
| 117 | positive regulation of synaptic transmission (GO:0050806) | 2.73672692 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.73671566 |
| 119 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.73299707 |
| 120 | atrial cardiac muscle cell action potential (GO:0086014) | 2.72540338 |
| 121 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.72277896 |
| 122 | cellular sodium ion homeostasis (GO:0006883) | 2.71958978 |
| 123 | cardiac conduction (GO:0061337) | 2.71835303 |
| 124 | negative regulation of amino acid transport (GO:0051956) | 2.71211392 |
| 125 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.69961917 |
| 126 | nucleobase catabolic process (GO:0046113) | 2.69769994 |
| 127 | fear response (GO:0042596) | 2.69394247 |
| 128 | L-amino acid import (GO:0043092) | 2.69143672 |
| 129 | synapse organization (GO:0050808) | 2.68888496 |
| 130 | regulation of respiratory system process (GO:0044065) | 2.68380775 |
| 131 | multicellular organismal signaling (GO:0035637) | 2.67828908 |
| 132 | dendrite morphogenesis (GO:0048813) | 2.67490902 |
| 133 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.67054717 |
| 134 | response to dietary excess (GO:0002021) | 2.66999279 |
| 135 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.64524542 |
| 136 | striatum development (GO:0021756) | 2.64372760 |
| 137 | L-serine transport (GO:0015825) | 2.62522378 |
| 138 | learning (GO:0007612) | 2.61207697 |
| 139 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.60312956 |
| 140 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.60306312 |
| 141 | regulation of protein kinase A signaling (GO:0010738) | 2.59759169 |
| 142 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.59018323 |
| 143 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.58951823 |
| 144 | potassium ion homeostasis (GO:0055075) | 2.57527425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.80505648 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.33329727 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88002610 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77242552 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.60060153 |
| 6 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40057412 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37948255 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37724358 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37724358 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.22213206 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22008134 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21010388 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20629401 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17072862 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16865239 |
| 16 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16856453 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15173310 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.14068459 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.12495383 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09567054 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09083116 |
| 22 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02580701 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99428664 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.93011047 |
| 25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.92904740 |
| 26 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91262047 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88250831 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84287130 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81085114 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77649945 |
| 31 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.77314177 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76631695 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76611262 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.76324118 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75588814 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74161167 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70989174 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69310838 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67147993 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57299845 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.55701138 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54531424 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54490812 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51469392 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50689235 |
| 46 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.49313432 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47823017 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47659145 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.47621612 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47460172 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45891038 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45582643 |
| 53 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45484971 |
| 54 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45445420 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45226608 |
| 56 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.44876083 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43482908 |
| 58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43388265 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42974072 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42884512 |
| 61 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40461790 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.40135719 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38665569 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33813337 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33711375 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32745328 |
| 67 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31613685 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29745207 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29484337 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28309030 |
| 71 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28005170 |
| 72 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.27269604 |
| 73 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25843312 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25592668 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25412370 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.25128895 |
| 77 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24824780 |
| 78 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.24620814 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23470353 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22736918 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22204709 |
| 82 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.21773454 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21349086 |
| 84 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21235441 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20529208 |
| 86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18638317 |
| 87 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18619641 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16773995 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16035017 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13770587 |
| 91 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12417207 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11720907 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11471167 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11064315 |
| 95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.10763781 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10242998 |
| 97 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09891049 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09091832 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09091832 |
| 100 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07379111 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06902110 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06150990 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05408888 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05234453 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04695978 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04695978 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03852106 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02536531 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00821525 |
| 110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99113593 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98908513 |
| 112 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98554221 |
| 113 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.97839572 |
| 114 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97839572 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97546175 |
| 116 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.96921603 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95722471 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94830372 |
| 119 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93345132 |
| 120 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92025029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.68344241 |
| 2 | MP0003880_abnormal_central_pattern | 3.76316423 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.41101127 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.16598752 |
| 5 | MP0005670_abnormal_white_adipose | 2.96699002 |
| 6 | MP0004270_analgesia | 2.94500921 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.82558926 |
| 8 | MP0009745_abnormal_behavioral_response | 2.81884839 |
| 9 | MP0009046_muscle_twitch | 2.68712155 |
| 10 | MP0002064_seizures | 2.67244046 |
| 11 | MP0004130_abnormal_muscle_cell | 2.51888073 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.44358082 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.42409346 |
| 14 | * MP0002572_abnormal_emotion/affect_behav | 2.38065797 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.32947915 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.30152226 |
| 17 | * MP0001486_abnormal_startle_reflex | 2.29414899 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.15191677 |
| 19 | MP0002272_abnormal_nervous_system | 2.14319917 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.13625560 |
| 21 | MP0005666_abnormal_adipose_tissue | 2.10335374 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.08155157 |
| 23 | MP0000749_muscle_degeneration | 2.05553367 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 2.00973870 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.00594486 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.98342114 |
| 27 | MP0002822_catalepsy | 1.91019478 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.86390192 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.80843934 |
| 30 | MP0002736_abnormal_nociception_after | 1.80007749 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.78680224 |
| 32 | MP0001984_abnormal_olfaction | 1.77482627 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.70017748 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.69619668 |
| 35 | MP0004924_abnormal_behavior | 1.69595030 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.69595030 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.61185804 |
| 38 | MP0002090_abnormal_vision | 1.60375416 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.59843776 |
| 40 | MP0000778_abnormal_nervous_system | 1.59073595 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.57350529 |
| 42 | MP0008569_lethality_at_weaning | 1.52491164 |
| 43 | MP0001970_abnormal_pain_threshold | 1.50933357 |
| 44 | MP0002184_abnormal_innervation | 1.49112454 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.47952238 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.44426911 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.38737893 |
| 48 | MP0000751_myopathy | 1.38191408 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.36309859 |
| 50 | MP0005535_abnormal_body_temperature | 1.36282059 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.36037002 |
| 52 | MP0006276_abnormal_autonomic_nervous | 1.35295681 |
| 53 | MP0005187_abnormal_penis_morphology | 1.33839607 |
| 54 | MP0003879_abnormal_hair_cell | 1.32243782 |
| 55 | MP0003787_abnormal_imprinting | 1.30681202 |
| 56 | MP0003633_abnormal_nervous_system | 1.29287959 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.26860447 |
| 58 | MP0002972_abnormal_cardiac_muscle | 1.26630248 |
| 59 | MP0003329_amyloid_beta_deposits | 1.25753564 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.22723390 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.21207083 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.20593332 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.17787738 |
| 64 | * MP0002066_abnormal_motor_capabilities/c | 1.17271975 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.16513434 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.15114974 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.14719282 |
| 68 | MP0001188_hyperpigmentation | 1.10752183 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.09119213 |
| 70 | MP0004858_abnormal_nervous_system | 1.08876876 |
| 71 | MP0004233_abnormal_muscle_weight | 1.07279560 |
| 72 | MP0004885_abnormal_endolymph | 1.05612475 |
| 73 | MP0002971_abnormal_brown_adipose | 1.04537348 |
| 74 | MP0000955_abnormal_spinal_cord | 1.04242298 |
| 75 | MP0005334_abnormal_fat_pad | 1.01382789 |
| 76 | MP0004510_myositis | 1.00496564 |
| 77 | MP0003690_abnormal_glial_cell | 1.00107650 |
| 78 | MP0005253_abnormal_eye_physiology | 0.97925771 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.97789239 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.97622945 |
| 81 | MP0003631_nervous_system_phenotype | 0.96841745 |
| 82 | MP0002229_neurodegeneration | 0.96768452 |
| 83 | MP0001177_atelectasis | 0.96674315 |
| 84 | MP0004087_abnormal_muscle_fiber | 0.94219984 |
| 85 | MP0003045_fibrosis | 0.94114446 |
| 86 | MP0001529_abnormal_vocalization | 0.93820508 |
| 87 | MP0005620_abnormal_muscle_contractility | 0.93139616 |
| 88 | MP0009115_abnormal_fat_cell | 0.91784483 |
| 89 | MP0002152_abnormal_brain_morphology | 0.90884193 |
| 90 | MP0004043_abnormal_pH_regulation | 0.88373675 |
| 91 | MP0001661_extended_life_span | 0.88071074 |
| 92 | MP0004484_altered_response_of | 0.86896297 |
| 93 | MP0005448_abnormal_energy_balance | 0.86701165 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.86532436 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.86282339 |
| 96 | MP0000516_abnormal_urinary_system | 0.86282339 |
| 97 | MP0002106_abnormal_muscle_physiology | 0.84753208 |
| 98 | MP0002269_muscular_atrophy | 0.83371467 |
| 99 | MP0001905_abnormal_dopamine_level | 0.81925088 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.81893492 |
| 101 | MP0005195_abnormal_posterior_eye | 0.81127100 |
| 102 | MP0000759_abnormal_skeletal_muscle | 0.80262173 |
| 103 | MP0004085_abnormal_heartbeat | 0.78741305 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.78477129 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.78312069 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.78020078 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.77975220 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.77021952 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.75890458 |
| 110 | MP0004142_abnormal_muscle_tone | 0.75530852 |
| 111 | MP0005452_abnormal_adipose_tissue | 0.75055842 |
| 112 | MP0003634_abnormal_glial_cell | 0.73878170 |
| 113 | MP0005385_cardiovascular_system_phenoty | 0.72869294 |
| 114 | MP0001544_abnormal_cardiovascular_syste | 0.72869294 |
| 115 | MP0005369_muscle_phenotype | 0.72500794 |
| 116 | MP0002108_abnormal_muscle_morphology | 0.72207942 |
| 117 | MP0003632_abnormal_nervous_system | 0.72081069 |
| 118 | MP0005171_absent_coat_pigmentation | 0.71598746 |
| 119 | MP0004742_abnormal_vestibular_system | 0.71253847 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.70701842 |
| 121 | MP0001943_abnormal_respiration | 0.70351863 |
| 122 | MP0008872_abnormal_physiological_respon | 0.70307280 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.69849784 |
| 124 | MP0000920_abnormal_myelination | 0.69798569 |
| 125 | MP0003137_abnormal_impulse_conducting | 0.68116684 |
| 126 | MP0005330_cardiomyopathy | 0.67928017 |
| 127 | MP0003279_aneurysm | 0.67301140 |
| 128 | MP0003122_maternal_imprinting | 0.67071323 |
| 129 | MP0008874_decreased_physiological_sensi | 0.66398390 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.65516992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.80864442 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.54914559 |
| 3 | Febrile seizures (HP:0002373) | 5.18480429 |
| 4 | Congenital stationary night blindness (HP:0007642) | 5.08947292 |
| 5 | Type 2 muscle fiber atrophy (HP:0003554) | 4.93131588 |
| 6 | Focal seizures (HP:0007359) | 4.70123550 |
| 7 | Popliteal pterygium (HP:0009756) | 4.52922453 |
| 8 | Sudden death (HP:0001699) | 4.50583528 |
| 9 | Visual hallucinations (HP:0002367) | 4.32403474 |
| 10 | Atonic seizures (HP:0010819) | 4.27569147 |
| 11 | Absence seizures (HP:0002121) | 4.22053301 |
| 12 | Muscle fiber atrophy (HP:0100295) | 4.09917734 |
| 13 | Hyperventilation (HP:0002883) | 4.07962613 |
| 14 | Oligomenorrhea (HP:0000876) | 3.98796185 |
| 15 | Central scotoma (HP:0000603) | 3.77113361 |
| 16 | Fetal akinesia sequence (HP:0001989) | 3.75405342 |
| 17 | Dialeptic seizures (HP:0011146) | 3.75337973 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.75235814 |
| 19 | Bundle branch block (HP:0011710) | 3.73878577 |
| 20 | Fatigable weakness (HP:0003473) | 3.70083383 |
| 21 | Abnormality of the neuromuscular junction (HP:0003398) | 3.70083383 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.63028267 |
| 23 | Syncope (HP:0001279) | 3.60242005 |
| 24 | Myokymia (HP:0002411) | 3.49248623 |
| 25 | Atrial fibrillation (HP:0005110) | 3.30319782 |
| 26 | Broad-based gait (HP:0002136) | 3.26047735 |
| 27 | Drooling (HP:0002307) | 3.25397383 |
| 28 | Excessive salivation (HP:0003781) | 3.25397383 |
| 29 | Abnormality of macular pigmentation (HP:0008002) | 3.22626257 |
| 30 | Amniotic constriction ring (HP:0009775) | 3.21199260 |
| 31 | Abnormality of placental membranes (HP:0011409) | 3.21199260 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 3.20084553 |
| 33 | Weak cry (HP:0001612) | 3.18765303 |
| 34 | Gowers sign (HP:0003391) | 3.17062642 |
| 35 | Akinesia (HP:0002304) | 3.16445460 |
| 36 | Abnormal eating behavior (HP:0100738) | 3.14507773 |
| 37 | Truncal ataxia (HP:0002078) | 3.10749627 |
| 38 | Calf muscle hypertrophy (HP:0008981) | 3.08161407 |
| 39 | Supraventricular tachycardia (HP:0004755) | 3.02502099 |
| 40 | Polyphagia (HP:0002591) | 3.01758579 |
| 41 | Limb dystonia (HP:0002451) | 2.97516114 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 2.96540241 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 2.95289015 |
| 44 | Supraventricular arrhythmia (HP:0005115) | 2.94614279 |
| 45 | Poor eye contact (HP:0000817) | 2.92241600 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.88308414 |
| 47 | Hyperthyroidism (HP:0000836) | 2.86235703 |
| 48 | Absent speech (HP:0001344) | 2.80192087 |
| 49 | Decreased muscle mass (HP:0003199) | 2.79831092 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.79778229 |
| 51 | Abnormal social behavior (HP:0012433) | 2.77190626 |
| 52 | Impaired social interactions (HP:0000735) | 2.77190626 |
| 53 | Action tremor (HP:0002345) | 2.71076681 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.69272470 |
| 55 | Hemiparesis (HP:0001269) | 2.65235656 |
| 56 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.61507387 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.58376889 |
| 58 | Diplopia (HP:0000651) | 2.57629062 |
| 59 | Abnormality of binocular vision (HP:0011514) | 2.57629062 |
| 60 | Amblyopia (HP:0000646) | 2.54559251 |
| 61 | Gait imbalance (HP:0002141) | 2.54195560 |
| 62 | Genetic anticipation (HP:0003743) | 2.53746268 |
| 63 | Depression (HP:0000716) | 2.52946908 |
| 64 | Left ventricular hypertrophy (HP:0001712) | 2.52814839 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 2.52545305 |
| 66 | Scotoma (HP:0000575) | 2.51535919 |
| 67 | Aplasia of the musculature (HP:0100854) | 2.47561729 |
| 68 | Papilledema (HP:0001085) | 2.46791702 |
| 69 | Dysmetric saccades (HP:0000641) | 2.45611914 |
| 70 | Nonprogressive disorder (HP:0003680) | 2.42150185 |
| 71 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37375149 |
| 72 | Abnormal EKG (HP:0003115) | 2.36252088 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.36193467 |
| 74 | Scanning speech (HP:0002168) | 2.36089354 |
| 75 | Anxiety (HP:0000739) | 2.35478470 |
| 76 | Supranuclear gaze palsy (HP:0000605) | 2.32233354 |
| 77 | Cystic hygroma (HP:0000476) | 2.31263753 |
| 78 | Mutism (HP:0002300) | 2.29432020 |
| 79 | Ventricular arrhythmia (HP:0004308) | 2.27761670 |
| 80 | Dysmetria (HP:0001310) | 2.27672955 |
| 81 | Abnormality of salivation (HP:0100755) | 2.25273182 |
| 82 | Hemiplegia (HP:0002301) | 2.23734411 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.22454039 |
| 84 | Abnormal hair whorl (HP:0010721) | 2.21769245 |
| 85 | Blue irides (HP:0000635) | 2.20908427 |
| 86 | Protruding tongue (HP:0010808) | 2.20744949 |
| 87 | Poor suck (HP:0002033) | 2.20518961 |
| 88 | Widely spaced teeth (HP:0000687) | 2.20461391 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.17955928 |
| 90 | Impaired smooth pursuit (HP:0007772) | 2.13834876 |
| 91 | Congenital primary aphakia (HP:0007707) | 2.12186129 |
| 92 | Postural instability (HP:0002172) | 2.10598320 |
| 93 | Heart block (HP:0012722) | 2.09270644 |
| 94 | Bradykinesia (HP:0002067) | 2.09053536 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08491433 |
| 96 | Subaortic stenosis (HP:0001682) | 2.08491433 |
| 97 | Medial flaring of the eyebrow (HP:0010747) | 2.08270274 |
| 98 | Spastic gait (HP:0002064) | 2.07224939 |
| 99 | Inappropriate behavior (HP:0000719) | 2.06960941 |
| 100 | Acanthosis nigricans (HP:0000956) | 2.06477769 |
| 101 | Lipoatrophy (HP:0100578) | 2.05428848 |
| 102 | Severe visual impairment (HP:0001141) | 2.04970838 |
| 103 | Progressive inability to walk (HP:0002505) | 2.04316151 |
| 104 | Easy fatigability (HP:0003388) | 2.02229852 |
| 105 | Pheochromocytoma (HP:0002666) | 2.02065092 |
| 106 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99584357 |
| 107 | Inability to walk (HP:0002540) | 1.97600798 |
| 108 | Ventricular fibrillation (HP:0001663) | 1.96047338 |
| 109 | Malignant hyperthermia (HP:0002047) | 1.95507397 |
| 110 | Lower limb muscle weakness (HP:0007340) | 1.94339763 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.93506896 |
| 112 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.93091396 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88427833 |
| 114 | Pterygium (HP:0001059) | 1.88107451 |
| 115 | Termporal pattern (HP:0011008) | 1.86839916 |
| 116 | Insidious onset (HP:0003587) | 1.86839916 |
| 117 | Intention tremor (HP:0002080) | 1.85945815 |
| 118 | Prolonged QT interval (HP:0001657) | 1.85480553 |
| 119 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84955244 |
| 120 | Stereotypic behavior (HP:0000733) | 1.84021700 |
| 121 | Aqueductal stenosis (HP:0002410) | 1.82920902 |
| 122 | Exotropia (HP:0000577) | 1.82847304 |
| 123 | Fair hair (HP:0002286) | 1.81231368 |
| 124 | Gait ataxia (HP:0002066) | 1.80974158 |
| 125 | Clumsiness (HP:0002312) | 1.80829290 |
| 126 | Retinal dysplasia (HP:0007973) | 1.80684309 |
| 127 | Incomplete penetrance (HP:0003829) | 1.80672652 |
| 128 | Hypoventilation (HP:0002791) | 1.78079671 |
| 129 | Impaired vibratory sensation (HP:0002495) | 1.77715345 |
| 130 | Neuroendocrine neoplasm (HP:0100634) | 1.77154090 |
| 131 | Abnormal atrioventricular conduction (HP:0005150) | 1.76461001 |
| 132 | Status epilepticus (HP:0002133) | 1.76338824 |
| 133 | Generalized myoclonic seizures (HP:0002123) | 1.74984122 |
| 134 | Torticollis (HP:0000473) | 1.74803315 |
| 135 | Decreased central vision (HP:0007663) | 1.73088660 |
| 136 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72499625 |
| 137 | Generalized hypopigmentation of hair (HP:0011358) | 1.71867226 |
| 138 | Ankle clonus (HP:0011448) | 1.71074470 |
| 139 | Thin ribs (HP:0000883) | 1.70171821 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.70069361 |
| 141 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.69890399 |
| 142 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.69890399 |
| 143 | Exercise-induced myalgia (HP:0003738) | 1.69160818 |
| 144 | Abnormality of the lower motor neuron (HP:0002366) | 1.68539231 |
| 145 | Resting tremor (HP:0002322) | 1.68500879 |
| 146 | Urinary urgency (HP:0000012) | 1.68303604 |
| 147 | Delayed gross motor development (HP:0002194) | 1.67855802 |
| 148 | Thyroid-stimulating hormone excess (HP:0002925) | 1.67149335 |
| 149 | Macroorchidism (HP:0000053) | 1.66577351 |
| 150 | Depressed nasal tip (HP:0000437) | 1.64876117 |
| 151 | Steppage gait (HP:0003376) | 1.63030856 |
| 152 | Metaphyseal dysplasia (HP:0100255) | 1.62448715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 3.94897200 |
| 2 | NTRK3 | 3.57633129 |
| 3 | MAP3K4 | 3.37027582 |
| 4 | EPHA4 | 3.22474099 |
| 5 | MARK1 | 3.22045537 |
| 6 | CASK | 2.96193606 |
| 7 | MAP2K7 | 2.84158279 |
| 8 | CAMK1D | 2.75260722 |
| 9 | CAMK1G | 2.64542304 |
| 10 | MAP3K9 | 2.33594614 |
| 11 | MINK1 | 2.07013564 |
| 12 | PAK6 | 1.98695492 |
| 13 | MAP2K4 | 1.97866866 |
| 14 | PLK2 | 1.76581944 |
| 15 | MAP3K12 | 1.76329332 |
| 16 | DAPK2 | 1.73498784 |
| 17 | NTRK2 | 1.72102787 |
| 18 | RIPK4 | 1.68545147 |
| 19 | PHKG2 | 1.66211013 |
| 20 | PHKG1 | 1.66211013 |
| 21 | BCR | 1.63102197 |
| 22 | UHMK1 | 1.62989103 |
| 23 | PRPF4B | 1.61840826 |
| 24 | MYLK | 1.61692270 |
| 25 | LIMK1 | 1.59371630 |
| 26 | TNIK | 1.48320258 |
| 27 | KSR1 | 1.48290813 |
| 28 | MAPK13 | 1.47535459 |
| 29 | GRK5 | 1.36999655 |
| 30 | AKT3 | 1.31796921 |
| 31 | CDK5 | 1.31716895 |
| 32 | INSRR | 1.30134155 |
| 33 | PRKD3 | 1.30062112 |
| 34 | DAPK1 | 1.29929835 |
| 35 | LMTK2 | 1.27169780 |
| 36 | OBSCN | 1.23994464 |
| 37 | KSR2 | 1.22624123 |
| 38 | CAMKK2 | 1.18809942 |
| 39 | CDK19 | 1.14856873 |
| 40 | PTK2B | 1.14803845 |
| 41 | FRK | 1.14110158 |
| 42 | PDK3 | 1.10211435 |
| 43 | PDK4 | 1.10211435 |
| 44 | SGK2 | 1.10049689 |
| 45 | PNCK | 1.00665998 |
| 46 | SIK1 | 1.00369872 |
| 47 | FES | 1.00221878 |
| 48 | PRKCG | 0.99105946 |
| 49 | MAP3K6 | 0.98249734 |
| 50 | SGK223 | 0.97237381 |
| 51 | SGK494 | 0.97237381 |
| 52 | DYRK1A | 0.97196414 |
| 53 | CAMK1 | 0.96515275 |
| 54 | STK38 | 0.96043676 |
| 55 | NME1 | 0.94843162 |
| 56 | CAMKK1 | 0.92358904 |
| 57 | CAMK2A | 0.89514658 |
| 58 | FGFR2 | 0.88002986 |
| 59 | EPHA3 | 0.87891017 |
| 60 | BMPR1B | 0.84389904 |
| 61 | DMPK | 0.83880909 |
| 62 | SIK2 | 0.82351805 |
| 63 | SGK1 | 0.82233619 |
| 64 | OXSR1 | 0.81627253 |
| 65 | PRKCE | 0.81146596 |
| 66 | NTRK1 | 0.80127873 |
| 67 | SGK3 | 0.78233270 |
| 68 | FER | 0.77897291 |
| 69 | MARK2 | 0.73826381 |
| 70 | BMPR2 | 0.72863994 |
| 71 | PIK3CA | 0.72664054 |
| 72 | PDK1 | 0.72580237 |
| 73 | STK11 | 0.72159327 |
| 74 | CSNK1A1L | 0.71608350 |
| 75 | RIPK1 | 0.71104655 |
| 76 | GRK7 | 0.70549639 |
| 77 | MAP3K13 | 0.70484535 |
| 78 | CAMK2B | 0.70281898 |
| 79 | PRKCH | 0.70050973 |
| 80 | MAP3K2 | 0.69960655 |
| 81 | RET | 0.68360663 |
| 82 | ROCK1 | 0.68268363 |
| 83 | PAK3 | 0.66537693 |
| 84 | CSNK1G1 | 0.66474201 |
| 85 | PDPK1 | 0.65153498 |
| 86 | MKNK2 | 0.64906520 |
| 87 | CSNK1G3 | 0.64828258 |
| 88 | CAMK2G | 0.64579508 |
| 89 | PRKAA2 | 0.64100471 |
| 90 | FGR | 0.64044965 |
| 91 | DYRK2 | 0.62448295 |
| 92 | ARAF | 0.57354329 |
| 93 | PKN1 | 0.57011270 |
| 94 | PRKCZ | 0.56461855 |
| 95 | MAPK12 | 0.56190838 |
| 96 | ACVR1B | 0.55943463 |
| 97 | MAP2K1 | 0.55837974 |
| 98 | MAP3K7 | 0.55720058 |
| 99 | PRKAA1 | 0.54557189 |
| 100 | ROCK2 | 0.54378343 |
| 101 | RAF1 | 0.54141837 |
| 102 | CDK3 | 0.53888771 |
| 103 | WNK3 | 0.53724332 |
| 104 | CDK14 | 0.52708486 |
| 105 | CDK18 | 0.51879220 |
| 106 | GRK1 | 0.51560010 |
| 107 | CAMK2D | 0.51167992 |
| 108 | STK39 | 0.49028189 |
| 109 | CDK15 | 0.48996785 |
| 110 | RPS6KA3 | 0.48818216 |
| 111 | FGFR3 | 0.48216650 |
| 112 | CSNK1G2 | 0.45901737 |
| 113 | PDK2 | 0.45672145 |
| 114 | TYRO3 | 0.42621409 |
| 115 | MAP3K5 | 0.42618031 |
| 116 | LATS2 | 0.42334267 |
| 117 | PINK1 | 0.42212244 |
| 118 | ERBB3 | 0.41643066 |
| 119 | PRKG1 | 0.41095519 |
| 120 | CAMK4 | 0.40956686 |
| 121 | PRKACB | 0.40720784 |
| 122 | PRKACA | 0.40237165 |
| 123 | TRIM28 | 0.40132596 |
| 124 | PRKD1 | 0.39757947 |
| 125 | FYN | 0.39651181 |
| 126 | MAPK10 | 0.37655700 |
| 127 | CCNB1 | 0.37463424 |
| 128 | ADRBK2 | 0.36889109 |
| 129 | CSNK1D | 0.31493291 |
| 130 | MAP4K2 | 0.30022000 |
| 131 | ADRBK1 | 0.29774008 |
| 132 | MAPK7 | 0.29092680 |
| 133 | PRKCA | 0.28090441 |
| 134 | CDK11A | 0.27812123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.65078170 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82219709 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75835669 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67708522 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.53484486 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.42333427 |
| 7 | Renin secretion_Homo sapiens_hsa04924 | 2.20407675 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.17019970 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16987769 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.14680930 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.14365874 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12879152 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.84112985 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82508826 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.82254252 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78729663 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78695436 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.64596376 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.61860852 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61232258 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57896635 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55373344 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54122254 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52997915 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51666355 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51632610 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.51426839 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48750958 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.48394429 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47318421 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42297877 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35690207 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30561542 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23234215 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19012131 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12076234 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10343300 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06478436 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06097050 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.05104575 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99555255 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99217451 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96147932 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95687561 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94867351 |
| 46 | Glioma_Homo sapiens_hsa05214 | 0.93830836 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.92759777 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92503364 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91519917 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89626617 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89003626 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88643891 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87226870 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85425267 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85371648 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84468501 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.80849940 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77244737 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77001116 |
| 60 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74677592 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73645366 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70739680 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70481019 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.70231857 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69731279 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68961089 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66802127 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65228862 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65200193 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65116062 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64076353 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63136514 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.62716535 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62679677 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61027743 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59825539 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59033600 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57372356 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55557089 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54389945 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54358902 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53522857 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52889340 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52306847 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52080955 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51396181 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51017255 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50204536 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47201924 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46111462 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45852520 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44446510 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44259678 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43471453 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42349572 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42051702 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41872051 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39568909 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39178922 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39118351 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38974334 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.37559786 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.37030086 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36388865 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36031080 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34796205 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34773819 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33378825 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32856945 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32218542 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32032178 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31796618 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30669657 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30251993 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30196950 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29623924 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29461679 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.27927778 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.27783277 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26114056 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25820501 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23269388 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.22381555 |

